181 results
Page 3 of 10
424B5
itlqhh g4s6rm
3 Sep 21
Prospectus supplement for primary offering
4:29pm
6-K
EX-99
d1lsd3n
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
6-K
EX-99
d9l0cu1wurc
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am
6-K
EX-99
xcfzc4fki90uz54xr49
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am
6-K
EX-1
bolb 2tf3rcqpf
15 Apr 21
BioLineRx Announces Presentation at 2021 American
4:01pm
6-K
54i10 0xvg
5 Apr 21
Current report (foreign)
4:30pm
6-K
EX-99
0xg0nyv 5qw9xe6m
26 Feb 21
Extraordinary General Meeting of Shareholders on
4:30pm
POS AM
dm4lp687er8iprn
23 Feb 21
Prospectus update (post-effective amendment)
9:12am
6-K
EX-99
6t0zmx4
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
36olpy i780pk
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
yfkp5d78a
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
ctmze9mp5
31 Dec 20
Shelf registration (foreign)
4:37pm
6-K
EX-99
j0wxgd1z60dx2fqf7
16 Dec 20
Current report (foreign)
8:00am
6-K
EX-99
n05pmvygd967
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
424B5
b56zu2vl8kqlu7m bnb
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
oyki2efc y7duwcs0
24 Sep 20
Current report (foreign)
4:30pm
6-K
EX-99
6svd 3488d95zisq
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm